37 ºC ROUNDTABLE DISCUSSION FOR INVESTORS IN LIFE SCIENCE TECHNOLOGY

The ROUNDTABLE DISCUSSION FOR INVESTORS IN LIFE SCIENCE TECHNOLOGY was held on 9TH MARCH 2017, 09:00-14:00 at Stavanger Forum. Among the 37 participants were several family offices, professional investors from Copenhagen, Tel Aviv, Oslo, Bergen and Stavanger. Azets, Diamond partner of 37 ºC Life Science Technology Conference & Exhibition was present. Also 3 students from Start UiS, involved in developing YOUNG 37 ºC were present. In addition to IP specialists brought in by Validé.

Henrik Lund, Chairman Oslo Cancer Cluster gave and Introduction & overview on Investing in life science technology companies; both Biotech and Medtech. Ludvik Sandnes Chairman of Nordic Nanovector gave a very interesting presentation of the history and IPO process of the company. After lunch, Ruti Alon, Founder & CEO of Medstrada and Asaf Iram, Investment Manager GlenRock Group offered their experiences and perspectives from Israeli life science. Mats Carlin, Board Member SINTEF TTO presented a selection of medtech cases. Before Øyvind Arnesen, CEO Ultimovacs shared experiences on how to manage early stage companies and make the right strategic decisions in the rapidly developing immunotherapy field.

The purpose of the Roundtable discussion was Experience sharing between Norwegian and international investors, on investing in life science tech/health tech/medtech/biotech. To share Nordic success stories, and the Israeli experience. And to raise awareness for the main event. Arne Hansson Rannestad, General Manager of 37 ºC Life Science Technology Conference & Exhibition 6th-7th June 2017 Stavanger Forum in Norway briefly presented the program which was well received by the audience.